Literature DB >> 16331433

Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women.

Aaron R Folsom1, Sherita Hill Golden, Lori L Boland, Moyses Szklo.   

Abstract

Oral exogenous estrogen raises C-reactive protein (CRP) concentrations, but the impact of endogenous hormones is unknown. We examined the cross-sectional relation of several serum hormones with CRP, fibrinogen, and white blood cell count - three inflammatory markers linked prospectively to coronary artery disease. Serum hormones were measured on a sample (n = 317) of postmenopausal female participants, with or without carotid intima-media thickening, in the Atherosclerosis Risk in Communities (ARIC) Study. Fibrinogen and white blood cell count were available on all and CRP in a subset (n = 57). Adjusted for age, race, and case-control status, mean CRP was 2-fold greater in the highest vs. lowest quartiles of estrone and androstenedione, and CRP was 2-fold less across quartiles of sex hormone binding globulin. These associations were not all statistically significant with this sample size. Fibrinogen and white blood cell count also were associated positively with estrone, androstenedione, and testosterone (and fibrinogen also with dehydroepiandrosterone sulfate). Adjustment for other risk factors and especially body mass index, a known determinant of endogenous hormone levels, attenuated most associations. In conclusion, several endogenous sex hormones may influence basal levels of inflammatory markers. Obesity appears to play a modulating role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331433     DOI: 10.1007/s10654-005-3657-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  43 in total

1.  Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.

Authors:  P Angerer; S Störk; W Kothny; P Schmitt; C von Schacky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

2.  Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.

Authors:  D Zanger; B K Yang; J Ardans; M A Waclawiw; G Csako; L M Wahl; R O Cannon
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

3.  The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.

Authors:  B W Walsh; S Paul; R A Wild; R A Dean; R P Tracy; D A Cox; P W Anderson
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial.

Authors:  Stefan Störk; Clemens von Schacky; Peter Angerer
Journal:  Atherosclerosis       Date:  2002-12       Impact factor: 5.162

5.  Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

Authors:  M Cushman; C Legault; E Barrett-Connor; M L Stefanick; C Kessler; H L Judd; P A Sakkinen; R P Tracy
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

6.  Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women.

Authors:  Esther M Brooks-Asplund; Carrie E Tupper; Jane M Daun; W Larry Kenney; Joseph G Cannon
Journal:  Cytokine       Date:  2002-08-21       Impact factor: 3.861

7.  Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.

Authors:  Wanpen Vongpatanasin; Meryem Tuncel; Zhongyun Wang; Debbie Arbique; Borna Mehrad; Ishwarlal Jialal
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

8.  Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort.

Authors:  Sherita Hill Golden; Ann Maguire; Jingzhong Ding; J R Crouse; Jane A Cauley; Howard Zacur; Moyses Szklo
Journal:  Am J Epidemiol       Date:  2002-03-01       Impact factor: 4.897

9.  Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Authors:  S Vehkavaara; A Silveira; T Hakala-Ala-Pietilä; A Virkamäki; O Hovatta; A Hamsten; M R Taskinen; H Yki-Järvinen
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  14 in total

1.  Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease.

Authors:  Ronald C Eldridge; Nicolas Wentzensen; Ruth M Pfeiffer; Louise A Brinton; Patricia Hartge; Chantal Guillemette; Troy J Kemp; Ligia A Pinto; Britton Trabert
Journal:  Cancer Causes Control       Date:  2020-02-25       Impact factor: 2.506

2.  Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

Authors:  L B Harrington; B T Marck; K L Wiggins; B McKnight; S R Heckbert; N F Woods; A Z LaCroix; M Blondon; B M Psaty; F R Rosendaal; A M Matsumoto; N L Smith
Journal:  J Thromb Haemost       Date:  2017-01-08       Impact factor: 5.824

3.  SHBG, sex hormones, and inflammatory markers in older women.

Authors:  Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; Anna Maria Corsi; Francesco Giallauria; Jack M Guralnik; Giovanni Zuliani; Chiara Cattabiani; Stefano Parrino; Fabrizio Ablondi; Elisabetta Dall'aglio; Graziano Ceresini; Shehzad Basaria; Luigi Ferrucci
Journal:  J Clin Endocrinol Metab       Date:  2011-01-14       Impact factor: 5.958

4.  Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Tetsuya Ohira; Aaron R Folsom; Mary Cushman; Richard H White; Peter J Hannan; Wayne D Rosamond; Susan R Heckbert
Journal:  Br J Haematol       Date:  2010-03-03       Impact factor: 6.998

5.  Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women.

Authors:  Roksana Karim; Frank Z Stanczyk; Howard N Hodis; Mary Cushman; Roger A Lobo; Juliana Hwang; Wendy J Mack
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

6.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

7.  C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China.

Authors:  J Ren; Z C Pang; W G Gao; H R Nan; S J Wang; L Zhang; Q Qiao
Journal:  Exp Diabetes Res       Date:  2010-11-07

8.  The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.

Authors:  Rita Rastogi Kalyani; Manuel Franco; Adrian S Dobs; Pamela Ouyang; Dhananjay Vaidya; Alain Bertoni; Susan M Gapstur; Sherita Hill Golden
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

9.  Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Lu Wang; Moyses Szklo; Aaron R Folsom; Nancy R Cook; Susan M Gapstur; Pamela Ouyang
Journal:  Atherosclerosis       Date:  2012-07-20       Impact factor: 5.162

10.  Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.

Authors:  Nicholas S Roetker; Richard F MacLehose; Ron C Hoogeveen; Christie M Ballantyne; Saonli Basu; Mary Cushman; Aaron R Folsom
Journal:  Thromb Haemost       Date:  2018-10-08       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.